On Monday, Pfizer and BioNTech announced in a press release that their vaccine candidate was more than 90 percent effective at preventing Covid-19 infection, based on initial results from their ongoing phase 3 clinical trial. The company expects to have applied for emergency use authorization with the Food and Drug Administration (FDA) by the end of November and could have as many as 50 million doses produces by the end of 2020.
This is tremendous news — and misinformation about it is already circulating on social media. According to research from VineSight, a slew of social Twitter accounts, including those of Donald Trump Jr. and Sen. Ted Cruz, are already questioning the timing of the results’ release just days after the presidential election. By midday, tweets pushing that narrative had racked up more than 20,000 shares. The researchers estimate that Donald Trump Jr.’s tweet alone could have been seen by nearly 7 million people.
The dream of bringing a speedy end to the pandemic is a complicated one. Even when a vaccine does win initial FDA authorization in the United States, we should expect a lengthy period of “chaos and confusion,” one expert recently told the New York Times. Much of that disarray could play out on social media.
From the possibility of multiple vaccines to regionally distinct distribution plans to still-evolving research, the process of vaccine implementation is already stoking anxiety and misinformation. Since the pandemic began, Facebook, Twitter, and YouTube have faced pressure to combat conspiracy theories about Covid-19 vaccines. When one or more vaccines are ultimately offered to the public, the companies will also need to continue to promote accurate information about ever-evolving public health precautions. And they must act sooner rather than later to grapple with the task of communicating and moderating this next period of the pandemic, according to Jennifer Reich, who has studied vaccine hesitance at the University of Colorado Denver.
“This is not going to be magic,” Reich told Recode. “I think that the way the vaccine has been messaged has been like, ‘Just wait till we have a vaccine and then we can all go back to life as normal.’ That’s probably not a realistic expectation.”
Public health and social media experts told Recode that social media companies should expect anti-vaccination communities to use social media to capitalize on peoples’ understandable concerns about a potential Covid-19 vaccine. At the same time, many will be confused and frustrated at the distribution of the vaccine, and some may be angry when they see others getting a vaccine before they do. That will come amid conspiracy theories and other misinformation that has already spread about potential Covid-19 vaccines.
Basically, it could be a very, very complicated mess.
Top Image Credit: Envato/Amanda Scott
SARS-CoV-2, the virus that causes COVID-19, likely does not directly infect the brain but can still inflict significant neurological damage, according to a new study from neuropathologists, neurologists, and neuroradiologists at Columbia University Vagelos [...]
ANSTO has contributed to a comprehensive investigation of a promising type of nanoparticle that could potentially be used for intractable brain cancers in a combined therapy. The study, which was led by Dr. Moeava [...]
The immune response needed to protect people against reinfection with the coronavirus will be explored in a new human challenge trial, researchers have revealed. Human challenge trials involve deliberately exposing healthy people to a [...]
Researchers from Duke University are developing a flu shot with the new technology that was used for two coronavirus vaccines. Both the Pfizer-BioNTech and the Moderna shots use part of the virus's genetic code [...]
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19. In a paper published in the journal Nanoscale, [...]
Researchers have developed a new superbug-destroying coating that could be used on wound dressings and implants to prevent and treat potentially deadly bacterial and fungal infections. The material is one of the thinnest antimicrobial [...]
The U.S. is recommending a "pause" in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. In a joint statement Tuesday, the Centers for Disease Control [...]
The South African coronavirus variant is better at "breaking through" the defences of the Pfizer/BioNTech vaccine than other forms of the virus, Israeli experts said Sunday. However, one of the authors told AFP that [...]
EPFL scientists have developed AI-powered nanosensors that let researchers track various kinds of biological molecules without disturbing them. The tiny world of biomolecules is rich in fascinating interactions between a plethora of different agents [...]
A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation of the cellular [...]
Researchers at Brown University have succeeded in creating the first wireless, implantable, rechargeable, long-term brain-computer interface. The wireless BCIs have been implanted in pigs and monkeys for over 13 months without issue, and human [...]
The coronavirus outbreak made household names of companies like Moderna Inc. and BioNTech SE, whose shots offered hope for ending the pandemic. Now a new wave of vaccines is on the horizon that may get the [...]
Researchers at the University of Southampton have developed a new way of using nanomaterials to identify and enrich skeletal stem cells—a discovery which could eventually lead to new treatments for major bone fractures and [...]
In March 2020, Hannu Rajaniemi pivoted his biotech company Helix Nanotechnologies' focus from cancer therapies to Covid-19 vaccines. The role biotech start-ups can play in a pandemic Rajaniemi originally co-founded Helix Nanotechnologies in Cambridge, Massachusetts in [...]
The rapid mass testing strategy costing just £1 a day per child can get children back to school and economies up and running, according to experts. That is the small price of the [...]
Covid-19 vaccines are incredibly good at preventing severe symptoms and hospitalization, but they’re probably less effective at stopping transmission. To do that, we might need a different kind of vaccine altogether. Because SARS-CoV-2 is [...]